23,574 Shares in Docusign Inc. $DOCU Bought by Hohimer Wealth Management LLC

Hohimer Wealth Management LLC bought a new position in shares of Docusign Inc. (NASDAQ:DOCU) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 23,574 shares of the company’s stock, valued at approximately $1,583,000.

A number of other hedge funds also recently added to or reduced their stakes in DOCU. BlackRock Inc. purchased a new position in Docusign in the second quarter valued at $927,059,000. Arrowstreet Capital Limited Partnership grew its stake in Docusign by 76.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock worth $250,568,000 after purchasing an additional 2,283,996 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Docusign by 4.0% during the 1st quarter. Renaissance Technologies LLC now owns 3,170,061 shares of the company’s stock worth $150,293,000 after purchasing an additional 123,100 shares during the period. Quantinno Capital Management LP increased its holdings in Docusign by 51.9% during the 1st quarter. Quantinno Capital Management LP now owns 1,608,631 shares of the company’s stock worth $76,265,000 after purchasing an additional 549,603 shares during the period. Finally, Bank of America Corp DE raised its position in Docusign by 23.3% in the 1st quarter. Bank of America Corp DE now owns 1,193,163 shares of the company’s stock valued at $56,568,000 after purchasing an additional 225,801 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DOCU has been the subject of several recent research reports. Robert W. Baird lifted their price objective on Docusign from $55.00 to $72.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. Morgan Stanley boosted their price objective on Docusign from $69.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. BTIG Research upped their target price on shares of Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Citizens Jmp reaffirmed a “market outperform” rating and issued a $86.00 target price on shares of Docusign in a report on Friday, September 4th. Finally, Wall Street Zen downgraded shares of Docusign from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 2nd. Three research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $67.62.

Docusign Trading Up 0.2%

Shares of DOCU stock opened at $77.75 on Tuesday. The company has a market cap of $14.53 billion, a P/E ratio of 47.92, a PEG ratio of 2.96 and a beta of 0.80. The firm has a fifty day moving average price of $72.88 and a 200 day moving average price of $55.34. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $85.90.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. The company had revenue of $875.75 million for the quarter, compared to analysts’ expectations of $867.22 million. Docusign had a return on equity of 18.29% and a net margin of 9.82%. Docusign’s quarterly revenue was up 9.4% on a year-over-year basis. During the same period last year, the firm earned $0.30 earnings per share. On average, equities analysts forecast that Docusign Inc. will post 2.15 EPS for the current year.

Insider Buying and Selling at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $69.29, for a total transaction of $1,818,862.50. Following the completion of the sale, the chief executive officer owned 166,801 shares in the company, valued at $11,557,641.29. The trade was a 13.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 14,676 shares of the business’s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $69.41, for a total value of $1,018,661.16. Following the sale, the insider owned 75,928 shares of the company’s stock, valued at approximately $5,270,162.48. The trade was a 16.20% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 154,168 shares of company stock worth $10,491,896. Corporate insiders own 0.59% of the company’s stock.

Docusign Profile

DocuSign, Inc provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes.

The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.

Founded in 2003, DocuSign serves customers across industries and operates internationally.